Among the various public portfolio startups of the fund, we may underline Cytrellis Biosystems Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Medical.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Merz Venture Initiative, startups are often financed by ARCH Venture Partners. The meaningful sponsors for the fund in investment in the same round are Partner Fund Management, Biomatics Capital Partners, ARCH Venture Partners.
The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
| Fund Name | Location |
| ASP Consulting | - |
| ATP | - |
| Cardworks | New York, United States, Woodbury |
| EMVC | District of Columbia, United States, Washington |
| Estar Capital | China, Shanghai |
| Fashion Capital Partners | France, Ile-de-France, Paris |
| Founders Forum | England, London, United Kingdom |
| Hospital for Special Surgery | New York, New York, United States |
| Huiruying Investment | China, Guangdong Province, Huizhou |
| ITV | England, London, United Kingdom |
| Jiadao Capital | - |
| Octave Group | New York, New York, United States |
| Rakuten Accelerator, Powered by Techstars | Central, Central Region, Singapore |
| Ransomshire Associates, Inc. | North Carolina, Rolesville, United States |
| Renoveru | Chiyoda, Japan |
| Roche Financial | Pennsylvania, United States, Williamsport |
| Sun Capital Partners | Boca Raton, Florida, United States |
| Taier Heavy Industry | Anhui, China, Maanshan |
| Texas A&M New Ventures Competition | College Station, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cytrellis Biosystems | $28M | 05 Jun 2018 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cytrellis Biosystems | $28M | 05 Jun 2018 | Boston, Massachusetts, United States |
